1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic bone marrow transplantation (allo-BMT) or autologous BMT (ABMT) for the treatment of pediatric patients with non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Boulad, F.; Gillio, A.; Gardner, S.; Kernan, N.; Small, T.; Van Syckle, K.; Williams, T.; Yahalom, J.; O'Reilly, R.
    Blood (1996)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
    Meeting Abstract

    Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Leukemia cells derived from relapsed and/or refractory patients that express multidrug resistant (MDR) protein P-gp 170 are sensitive to lysis by natural killer cell line NK-92
    Meeting Abstract

    Yan, Y.; Koo, K.; Collins, N. H.; O'Reilly, R. J.
    Blood (1996)

    Fulltext@MSK | Save
  • Analysis of opportunistic infections in 423 patients following allogeneic unmodified or T cell depleted (TCD) related or unrelated bone marrow transplantation
    Meeting Abstract

    Small, T.; Boulad, F.; Kernan, N.; Szabolcs, P.; Van Syckle, K.; Papadopoulos, E.; Black, P.; Taylor, J.; Childs, B.; Young, J.; more...
    Blood (1996)

    Fulltext@MSK | Save
  • Economic evaluation of G-CSF use in the therapy of adult acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Berman, E.; Tyson, D.; Scheinberg, D.
    Blood (1996)

    Fulltext@MSK | Save
  • High-dose infusional humanized anti-CD33 M195: Prospects for treating minimal disease in myeloid leukemia
    Meeting Abstract

    Caron, P. C.; Jurcic, J. G.; Dumont, L.; Tyson, D.; Scheinberg, D. A.
    Blood (1996)

    Fulltext@MSK | Save
  • Initial clinical study of a novel organic arsenical, melarsoprol, in patients with advanced leukemia
    Meeting Abstract

    Soignet, S.; Tong, W. P.; Gabrilove, J.; Scheinberg, D. A.; Pandolfi, P. P.; Warrell, R. P. Jr
    Blood (1996)

    Fulltext@MSK | Save
  • In-vitro and in-vivo anti-leukemic activity of a natural killer (NK) cell clone against both primary human leukemias and leukemic cell lines
    Meeting Abstract

    Yan, Y.; McGuirk, J.; Steinherz, P.; O'Reilly, R. J.
    Blood (1996)

    Fulltext@MSK | Save
  • Reduced acute and chronic graft versus host disease (GVHD) do not compromise leukemia free survival following T-cell depleted (SBA "E") unrelated marrow transplants for pediatric acute lymphoblastic leukemia
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Gillio, A.; Small, T.; Van Syckle, K.; Szabolcs, P.; Collins, N. H.; Yang, S. Y.; Landrey, C.; Mitchell-Grant, J.; more...
    Blood (1996)

    Fulltext@MSK | Save
  • High dose therapy with autologous stem cell rescue in pediatric patients with refractory Hodgkin's disease
    Meeting Abstract

    Gardner, S.; Boulad, F.; Gillio, A.; Kernan, N.; O'Reilly, R.; Small, T.; Szabolcs, P.; Tan, C.; Ganshaw, L.; Van Syckle, K.; more...
    Blood (1996)

    Fulltext@MSK | Save